ArticleNature communications2021
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques.
Open access · goldAbstract read
In one paragraph
Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.
0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
60 citing papers in PubMed, 87 citations in OpenAlex.
- Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.PloS one · 2021Trial
- Exposure route, not dose, is the primary driver of infection patterns for a respiratory virus.Science advances · 2026Article
- Exposure route drives SARS-CoV-2 infection patterns in non-human primates.bioRxiv : the preprint server for biology · 2026Article
- A narrative review and expert opinion on immunity-targeted approaches in the management of viral upper respiratory tract infections.NPJ primary care respiratory medicine · 2025Review
- Emerging SARS-CoV-2 variants: genomic shifts, immune evasion, and therapeutic perspectives.Molecular biology reports · 2025Review
- When less is statistically Equivalent: Lobe-Specific optimization of histopathological assessment in SARS-CoV-2 pneumonia.Computers in biology and medicine · 2025Article
- Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.PLoS pathogens · 2025Article
- SARS-CoV-2: The Interplay Between Evolution and Host Immunity.Annual review of immunology · 2025Review
- Pulmonary lymphoid tissue induced after SARS-CoV-2 infection in rhesus macaques.Frontiers in immunology · 2025Article
- Testing of tissue specimens obtained from SARS-CoV-2 nasopharyngeal swab-positive donors.Cell and tissue banking · 2024Article
- SARS-CoV-2 immunity in animal models.Cellular & molecular immunology · 2024Review
- Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models.Human vaccines & immunotherapeutics · 2023Article
- Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19.Vaccines · 2023Article
- Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection.Small methods · 2023Article
- Acute bone loss following SARS-CoV-2 infection in mice.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023Article
- Article
- Pre-clinical models to define correlates of protection for SARS-CoV-2.Frontiers in immunology · 2023Review
- Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccines.PloS one · 2023Article
- COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan.Cell discovery · 2022Article
- Dam-Infant Rhesus Macaque Pairs to Dissect Age-Dependent Responses to SARS-CoV-2 Infection.ImmunoHorizons · 2022Article
Corrections and comments
- Update of
- Update of
Authors and funding
33 authors at 5 institutions in 1 country.
Yashavanth Shaan Lakshmanappa *Center for Immunology and Infectious Diseases, UC Davis, Davis, CA, USA.ORCID 0000-0002-7794-1963
Sonny R Elizaldi *Center for Immunology and Infectious Diseases, UC Davis, Davis, CA, USA.
Jamin W Roh *Center for Immunology and Infectious Diseases, UC Davis, Davis, CA, USA.
Brian A Schmidt *Center for Immunology and Infectious Diseases, UC Davis, Davis, CA, USA.
Timothy D Carroll *California National Primate Research Center, UC Davis, Davis, CA, USA.
Kourtney D WeaverDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Justin C SmithDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.ORCID 0000-0001-7702-7920
Anil VermaCenter for Immunology and Infectious Diseases, UC Davis, Davis, CA, USA.
Jesse D DeereCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.
Joseph DutraCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.
Mars StoneDepartment of Laboratory Medicine, University of California, San Francisco, CA, USA.
Sergej FranzVitalant Research Institute, San Francisco, CA, USA.
Rebecca Lee SammakCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.
Katherine J OlstadCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.
J Rachel ReaderCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.ORCID 0000-0003-3864-6731
Zhong-Min MaCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.ORCID 0000-0003-3713-7337
Nancy K NguyenCenter for Immunology and Infectious Diseases, UC Davis, Davis, CA, USA.
Jennifer WatanabeCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.ORCID 0000-0001-9408-3991
Jodie UsachenkoCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.
Ramya ImmareddyCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.
JoAnn L YeeCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.ORCID 0000-0002-5514-9836
Daniela WeiskopfCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.
Dennis Hartigan-O'ConnorCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.
Stephen J McSorleyCenter for Immunology and Infectious Diseases, UC Davis, Davis, CA, USA.
John H MorrisonCalifornia National Primate Research Center, UC Davis, Davis, CA, USA.
Nam K TranPathology and Laboratory Medicine, School of Medicine, UC Davis, Davis, CA, USA.
Graham SimmonsDepartment of Laboratory Medicine, University of California, San Francisco, CA, USA.
Michael P BuschDepartment of Laboratory Medicine, University of California, San Francisco, CA, USA.
Pamela A KozlowskiDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.ORCID 0000-0001-9906-6234
Koen K A Van RompayCalifornia National Primate Research Center, UC Davis, Davis, CA, USA. kkvanrompay@ucdavis.edu.ORCID 0000-0002-7375-1337
Christopher J MillerCenter for Immunology and Infectious Diseases, UC Davis, Davis, CA, USA. cjmiller@ucdavis.edu.ORCID 0000-0002-1381-1975
Smita S IyerCenter for Immunology and Infectious Diseases, UC Davis, Davis, CA, USA. smiyer@ucdavis.edu.ORCID 0000-0002-8918-7005
University of California, Davis · USLouisiana State University Health Sciences Center New Orleans · USUniversity of California, San Francisco · USLa Jolla Institute for Immunology · USPacific Research Institute · US
Funding
National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5MNonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1MResource for Nonhuman Primate Cell Depleting AntibodiesR24OD010976 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ENGELMAN, KATHLEEN, MAGNANI, DIOGO · 2012 to 2019
$4.7MAnimal Models of Infectious Diseases Training ProgramT32AI060555 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI MCSORLEY, STEPHEN J · 2004 to 2025
$3.3MRole of female genital mucosa associated CD4 T cells in vaccine-induced HIV susceptibilityR21AI143454 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IYER, SWAMINATHAN SMITA · 2019 to 2020
$623kNIAID NIH HHS R21 AI143454NIAID NIH HHS T32 AI060555NIAID NIH HHS U24 AI126683NIH HHS P51 OD011107NIH HHS R24 OD010976
Abstract
CD4 T follicular helper (T
Indexed as
AnimalsAntibodies, ViralCell LineChlorocebus aethiopsCoronavirus Nucleocapsid ProteinsCOVID-19COVID-19 SerotherapyDisease Models, AnimalFemaleGerminal CenterHumansImmunity, HumoralImmunization, PassiveImmunogenicity, VaccineImmunoglobulin GMacaca mulattaAntibodies, ViralCoronavirus Nucleocapsid ProteinsImmunoglobulin Gnucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.